Class A scavenger receptor (CD204) attenuates hyperoxia-induced lung injury by reducing oxidative stress

Journal of Pathology

Volumn 212, Issue 1, 2007, Pages 38-46

  Kobayashi, H ^a   Sakashita, N ^a   Okuma, T ^a   Terasaki, Y ^a   Tsujita, K ^a   Suzuki, H ^b   Kodama, T ^c   Nomori, H ^a   Kawasuji, M ^a   Takeya, M ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Class A scavenger receptor (CD204); Hyperoxic lung injury; Inducible nitric oxide synthase; Macrophages; Oxidative stress; Tumour necrosis factor

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; SCAVENGER RECEPTOR A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRY WEIGHT; GENE EXPRESSION; HISTOPATHOLOGY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; LUNG WEIGHT; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; HYPEROXIA; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RESPIRATORY DISTRESS SYNDROME, ADULT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS A; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 34248569783     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2150     Document Type: Article

References (43)

1. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999;49:91-102.
2. Frank L, Bucher JR, Roberts RJ. Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol 1978;45:699.
3. Fischer AB, Forman HJ, Glass M. Mechanisms of pulmonary oxygen toxicity. Lung 1984;162:255-259.
4. Chabot F, Mitchell JA, Gutteridge JM, Evans TW. Reactive oxygen species in acute lung injury. Eur Respir J 1998;11:745-757.
5. Guthmann F, Wissel H, Schachtrup C, Tolle A, Rudiger M, Spener F, et al. Inhibition of TNF-alpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells. Respir Res 2005;6:10.
6. Lindsay L, Oliver SJ, Freeman SL, Josien R, Krauss A, Kaplan G. Modulation of hyperoxia-induced TNF-alpha expression in the newborn rat lung by thalidomide and dexamethasone. Inflammation 2000; 24:347-356.
7. 2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res 1995;21:589-597.
8. Worrall NK, Chang K, LeJeune WS, Misko TP, Sullivan PM, Ferguson TB Jr, et al. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and - independent mechanisms. Am J Physiol 1997;273:2565-2574.
9. Kobayashi H, Hataishi R, Mitsufuji H, Tanaka M, Jacobson M, Tomita T, et al. Antiinflammatory properties of inducible nitric oxide synthase in acute hyperoxic lung injury. Am J Respir Cell Mol Biol 2001; 24:390-397.
10. Hesse AK, Dorger M, Kupatt C, Krombach F. Proinflammatory role of inducible nitric oxide synthase in acute hyperoxic lung injury. Respir Res 2004;5:11.
11. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994; 94:2407-2413.
12. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997;386:292-296.
13. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, et al. The multiple roles of macrophage scavenger receptors (MSR) in vivo : resistance to atherosclerosis and susceptibility to infection in MSR knockout mice. J Atheroscler Thromb 1997;4:1-11.
14. Sakaguchi H, Takeya M, Suzuki H, Hakamata H, Kodama T, Horiuchi S, et al. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab Invest 1998;78:423-434.
15. Krieger M, Acton S, Ashkenas J, Person A, Penman M, Resnick D. Molecular flypaper, host defense, and atherosclerosis. J Biol Chem 1993; 268:4569-4572.
16. Mori T, Takahashi K, Higashi T, Takeya M, Kume S, Kawabe Y, et al. Localization of advanced glycation end products of Millard reaction in bovine tissues and their endocytosis by macrophage scavenger receptors. Exp Mol Pathol 1995;63:135-152.
17. Platt N, Haworth R, Darley L, Gordon S. The many roles of the class A macrophage scavenger receptor. Int Rev Cytol 2002;212:1-40.
18. Ozeki Y, Tsutsui H, Kawada N, Suzuki H, Kataoka M, Kodama T, et al. Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. Microb Pathog 2006;40:171-176.
19. Haworth R, Platt N, Keshav S, Hughes D, Darley E, Suzuki H, et al. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med 1997;186:1431-1439.
20. Beamer CA, Holian A. Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am J Physiol Lung Cell Mol Physiol 2005;289:186-195.
21. Okuma T, Terasaki Y, Sakashita N, Kaikita K, Kobayashi H, Hayasaki T, et al. MCP-1/CCR2 signaling is involved in hyperoxia-induced acute lung injury by regulating nitric oxide production. Int J Exp Pathol 2006;87:475-483.
22. Okuma T, Terasaki Y, Kaikita K, Kobayashi H, Kuziel WA, Kawasuji M, et al. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. J Pathol 2004;204:594-604.
23. Tomokiyo R, Jinnouchi K, Honda M, Wada Y, Hanada N, Hiraoka T, et al. Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors. Atherosclerosis 2002;161:123-132.
24. Crapo JD, Barry BE, Foscue HA, Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptative doses of oxygen. Am Rev Respir Dis 1980;122:123-143.
25. Narasaraju TA, Jin N, Narendranath CR, Chen Z, Gou D, Liu L. Protein nitration in rat lungs during hyperoxia exposure: a possible role of myeloperoxidase. Am J Physiol Lung Cell Mol Physiol 2003; 285:1037-1045.
26. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994; 94:2407-2413.
27. Glosli H, Tronstad KJ, Wergedal H, Muller F, Svardal A, Aukrust P, et al. Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes. FASEB J 2002;16:1450-1452.
28. Brown LA, Harris FL, Guidot DM. Chronic ethanol ingestion potentiates TNF-alpha-mediated oxidative stress and apoptosis in rat type II cells. Am J Physiol Lung Cell Mol Physiol 2001;281:377-386.
29. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
30. Schulz C, Gillissen A, Schultze-Werninghaus G. Inducible nitric oxide synthase in pulmonary inflammatory processes. Pneumologie 1998; 52:340-349.
31. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 1997;11:955-964.
32. Ermert M, Ruppert C, Gunther A, Duncker HR, Seeger W, Ermert L. Cell-specific nitric oxide syrithase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 2002; 82:425-441.
33. Mehta S. The effects of nitric oxide in acute lung injury. Vascul Pharmacol 2005;43:390-403.
34. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 1994; 375:81-88.
35. Eiselich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Hailliwell B, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393-397.
36. Ben-Ari J, Makhoul IR, Dorio RJ, Buckley S, Warburton D, Walker SM. Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats. Isr Med Assoc J 2000;2:365-369.
37. Desmarquest P, Chadelat K, Corroyer S, Cazals V, Clement A. Effect of hyperoxia on human macrophage cytokine response. Respir Med 1998;92:951-960.
38. Wherry JC, Pennington JE, Wenzel RP. Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies. Crit Care Med 1993;21:436-440.
39. Coller SP, Paulnock DM. Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. J Leukoc Biol 2001;70:142-148.
40. 2 production and suppression of IL-12 release in murine macrophages. J Leukoc Biol 2004;76:1066-1074.
41. Platt N, Gordon S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. J. Clin Invest 2001; 108:649-654.
42. Lee PJ, Choi AM. Pathways of cell signaling in hyperoxia. Free Radic Biol Med 2003;35:341-350.
43. Pepperl S, Dorger M, Ringel F, Kupatt C, Krombach F. Hyperoxia upregulates the NO pathway in alveolar macrophages in vitro: role of AP-1 and NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2001; 280:905-913.